BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 33001409)

  • 1. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
    Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
    Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.
    Pilgram L; Eberwein L; Wille K; Koehler FC; Stecher M; Rieg S; Kielstein JT; Jakob CEM; Rüthrich M; Burst V; Prasser F; Borgmann S; Müller RU; Lanznaster J; Isberner N; Tometten L; Dolff S;
    Infection; 2021 Aug; 49(4):725-737. PubMed ID: 33851328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.
    Auvinen R; Nohynek H; Syrjänen R; Ollgren J; Kerttula T; Mäntylä J; Ikonen N; Loginov R; Haveri A; Kurkela S; Skogberg K
    Infect Dis (Lond); 2021 Feb; 53(2):111-121. PubMed ID: 33170050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
    Zellmer S; Hanses F; Muzalyova A; Classen J; Braun G; Piepel C; Erber J; Pilgram L; Walter L; Göpel S; Wille K; Hower M; Rüthrich MM; Rupp J; Degenhardt C; Voigt I; Borgmann S; Stecher M; Jakob C; Dhillon C; Messmann H; Ebigbo A; Römmele C;
    United European Gastroenterol J; 2021 Nov; 9(9):1081-1090. PubMed ID: 34655180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
    Hakeam HA; Alsemari M; Duhailib ZA; Ghonem L; Alharbi SA; Almutairy E; Sheraim NMB; Alsalhi M; Alhijji A; AlQahtani S; Khalid M; Barry M
    J Cardiovasc Pharmacol Ther; 2021 May; 26(3):244-252. PubMed ID: 33231487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality).
    Pilgram L; Eberwein L; Jensen BO; Jakob CEM; Koehler FC; Hower M; Kielstein JT; Stecher M; Hohenstein B; Prasser F; Westhoff T; de Miranda SMN; Vehreschild MJGT; Lanznaster J; Dolff S;
    Infection; 2023 Feb; 51(1):71-81. PubMed ID: 35486356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
    Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
    Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany.
    Koppe U; Schilling J; Stecher M; Rüthrich MM; Marquis A; Diercke M; Haselberger M; Koll CEM; Niebank M; Ruehe B; Borgmann S; Grabenhenrich L; Hellwig K; Pilgram L; Spinner CD; Paerisch T;
    BMC Infect Dis; 2023 Feb; 23(1):89. PubMed ID: 36765274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.
    Bonnet G; Weizman O; Trimaille A; Pommier T; Cellier J; Geneste L; Panagides V; Marsou W; Deney A; Attou S; Delmotte T; Ribeyrolles S; Chemaly P; Karsenty C; Giordano G; Gautier A; Chaumont C; Guilleminot P; Sagnard A; Pastiero J; Ezzouhairi N; Perin B; Zakine C; Levasseur T; Ma I; Chavignier D; Noirclerc N; Darmon A; Mevelec M; Duceau B; Sutter W; Mika D; Fauvel C; Pezel T; Waldmann V; Cohen A;
    Arch Cardiovasc Dis; 2021 May; 114(5):352-363. PubMed ID: 34154953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.
    Pilgram L; Appel KS; Ruethrich MM; Koll CEM; Vehreschild MJGT; de Miranda SMN; Hower M; Hellwig K; Hanses F; Wille K; Haselberger M; Spinner CD; Vom Dahl J; Hertenstein B; Westhoff T; Vehreschild JJ; Jensen BO; Stecher M
    Infection; 2023 Aug; 51(4):1033-1049. PubMed ID: 36763285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.
    Leulseged TW; Abebe KG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Bayisa AB; Siyoum DF; Edo MG; Mesfin EG; Derejie MN; Shiferaw HK
    PLoS One; 2022; 17(1):e0262896. PubMed ID: 35085338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
    Nägele MP; Haubner B; Tanner FC; Ruschitzka F; Flammer AJ
    Atherosclerosis; 2020 Dec; 314():58-62. PubMed ID: 33161318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The COVID-19 Pandemic as an Opportunity and Challenge for Registries in Health Services Research: Lessons Learned from the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS)].
    Pilgram L; Schons M; Jakob CEM; Claßen AY; Franke B; Tscharntke L; Schulze N; Fuhrmann S; Sauer G; de Miranda SMN; Prasser F; Stecher M; Vehreschild JJ
    Gesundheitswesen; 2021 Nov; 83(S 01):S45-S53. PubMed ID: 34731893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of severe COVID-19: A systematic review and meta-analysis.
    Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
    Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry.
    Cremer S; Jakob C; Berkowitsch A; Borgmann S; Pilgram L; Tometten L; Classen A; Wille K; Weidlich S; Gruener B; Dimmeler S; Massberg S; Rieg S; Zeiher AM;
    Clin Res Cardiol; 2021 Jul; 110(7):1029-1040. PubMed ID: 33211155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis.
    Brito-Zerón P; Gracia-Tello B; Robles A; Alguacil A; Bonet M; De-Escalante B; Noblejas-Mosso A; Gómez-de-la-Torre R; Akasbi M; Pérez-de-Lis M; Pérez-Alvarez R; Ramos-Casals M; On Behalf Of The SarcoGEAS-Semi Registry
    Viruses; 2021 May; 13(6):. PubMed ID: 34071924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.